Falchion, they have stated that they are fully funded to complete phase 2 trials for acne and dermatitis and phase 1 for psoriasis and they have done partnership for microbial but if phase 1 psoriasis results are good there are 3 options. Raise more, do a deal or put on backburner. I am hoping for a partnership similar to University of Queensland but we will see.
Like i said if they raise more i will just have to average down. If CBD works as well as i think it does this will be a multi faceted monster!
Ann: Ethics Approval for BTX 1308 Psoriasis Patient Study Secured, page-27
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 35.0¢ | $230.9K | 653.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 89180 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 138744 | 8 |
View Market Depth
| Last trade - 10.50am 27/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
